1. Discuss how adeno-associated viruses (AAV) are used as gene therapy vectors.
  2. Review the current state-of-the art potential of AAV vectors to treat neurological diseases
  3. Discuss the current limitations of AAV vectors to treat neurological diseases
  4. Discuss how new AAV technology improvements are poised to revolutionize CNS gene therapy
Session date: 
10/14/2026 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center D1.602
Dallas, TX 75390
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.